These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6805233)

  • 21. [Immunologic and histomorphologic features of responsiveness in patients with leprosy at different stages of treatment].
    Strukov AI; Babaiants RS; Shakhtmeĭster IIa; Kopieva TN; Goloschapov NM
    Vestn Dermatol Venerol; 1972 Oct; 46(10):8-12. PubMed ID: 4569353
    [No Abstract]   [Full Text] [Related]  

  • 22. Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR.
    Job CK; Jayakumar J; Kearney M; Gillis TP
    Am J Trop Med Hyg; 2008 Mar; 78(3):518-21. PubMed ID: 18337353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural alterations of mycobacterium leprae in skin biopsies of untreated and treated lepromatous patients.
    Silva MT; Macedo PM; Costa MH; Gonçalves H; Torgal J; David HL
    Ann Microbiol (Paris); 1982; 133(1):75-92. PubMed ID: 7051933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on sulfone resistance in leprosy. I. Detection of cases.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of patients in the THELEP trials of chemotherapy of leprosy at Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Mar; 58(1):7-16. PubMed ID: 3298905
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].
    Bourland J; Van Loo L; Pattyn SR
    Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 31. Progress in the chemotherapy of leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
    [No Abstract]   [Full Text] [Related]  

  • 32. Activity of thiozamin (p-(p'-aminobenzenesulfonyl)-benzaldehyde thiosemicarbazone) against Mycobacterium leprae infections in mice.
    Matsuo Y
    Jpn J Microbiol; 1971 Jan; 15(1):93-4. PubMed ID: 4927841
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
    Salamatina OS; Diachina MN; Iushchenko AA; Chernousova LN; Kalinina ON; Parshin MP
    Probl Tuberk; 2001; (8):49-51. PubMed ID: 11767394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Leprosy research].
    Luger A
    Wien Klin Wochenschr; 1971 Mar; 83(10):161-5. PubMed ID: 4327066
    [No Abstract]   [Full Text] [Related]  

  • 35. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with 4,4'-diacetyldiaminodiphenylsulfone (DADDS) of leprosy patients in the Karimui, New Guinea.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1971 May; 20(3):495-501. PubMed ID: 4932529
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients.
    Grange JM; Beck JS; Abbot NC
    Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prevention of the leprous reaction].
    Bergel M
    Ther Ggw; 1971 Oct; 110(10):1471-6. PubMed ID: 5003860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.